Loratadine reduces the expression of ICAM-1.
Ciprandi
G
G
Allergy and Clinical Immunology Service, Department of Internal Medicine-DI.M.I., Genoa, Italy.
Catrullo
A
A
Cerqueti
P
P
Tosca
M
M
Fiorino
N
N
Canonica
G W
GW
D000293:Adolescent; D000328:Adult; D018926:Anti-Allergic Agents / Q000494:pharmacology*; D003228:Conjunctiva / Q000378:metabolism / Q000473:pathology; D003233:Conjunctivitis, Allergic / Q000276:immunology / Q000378:metabolism; D004311:Double-Blind Method; D004848:Epithelium / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism*; D017336:Loratadine / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D010940:Plant Proteins / Q000276:immunology; D011058:Pollen / Q000276:immunology; D006255:Rhinitis, Allergic, Seasonal / Q000276:immunology / Q000378:metabolism
D018926:Anti-Allergic Agents; D010940:Plant Proteins; D018799:Intercellular Adhesion Molecule-1; D017336:Loratadine